Epigenetic licensing of pancreatic cancer metastasis
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210814
- Recipient
-
Fundacio Institut De Recerca Biomedica (Irb Barcelona) UEI Q1QYYSBN8M88
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $357,500
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Spain
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $357,500 Project Grant to Fundacio Institut De Recerca Biomedica (Irb Barcelona) to support research titled "Epigenetic Licensing of Pancreatic Cancer Metastasis." The award period is from September 30, 2022 through September 29, 2025.
The grant is being funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research aimed at transforming military and public health care through innovative medical solutions for battlefield injuries and other health issues. Specifically, this Project Grant will further Irb Barcelona's research into the epigenetic mechanisms that license the metastasis of pancreatic cancer, with the goal of gaining new insights that could lead to improved prevention and treatment strategies for this disease.
Quick answers
Who received award W81XWH2210814?
W81XWH2210814 was awarded to Fundacio Institut De Recerca Biomedica (Irb Barcelona) by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2210814 worth?
$357,500 has been obligated on W81XWH2210814.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award